CN1943724A - 一种用于偏头痛的中药组合物及其制备方法 - Google Patents
一种用于偏头痛的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN1943724A CN1943724A CN 200510105966 CN200510105966A CN1943724A CN 1943724 A CN1943724 A CN 1943724A CN 200510105966 CN200510105966 CN 200510105966 CN 200510105966 A CN200510105966 A CN 200510105966A CN 1943724 A CN1943724 A CN 1943724A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- rhizoma
- extract
- powder
- rhizoma chuanxiong
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims description 13
- 208000019695 Migraine disease Diseases 0.000 title abstract description 14
- 206010027599 migraine Diseases 0.000 title abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 27
- 241000628997 Flos Species 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 51
- 239000000843 powder Substances 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000008280 blood Substances 0.000 claims description 19
- 210000004369 blood Anatomy 0.000 claims description 17
- 241001643642 Viticis Species 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 14
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 14
- 239000000341 volatile oil Substances 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 8
- 206010013786 Dry skin Diseases 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 230000006837 decompression Effects 0.000 claims description 7
- 238000004821 distillation Methods 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 7
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000019634 flavors Nutrition 0.000 claims description 7
- 238000001556 precipitation Methods 0.000 claims description 7
- 238000004064 recycling Methods 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 229930189533 tanshinol Natural products 0.000 claims description 7
- 206010041956 Stasis syndrome Diseases 0.000 claims description 4
- 208000005634 blind loop syndrome Diseases 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 6
- 241000305492 Gastrodia Species 0.000 abstract 1
- 241000244355 Ligusticum Species 0.000 abstract 1
- 239000000047 product Substances 0.000 description 18
- 238000002156 mixing Methods 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 229960004756 ethanol Drugs 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 8
- 102100025588 Calcitonin gene-related peptide 1 Human genes 0.000 description 8
- 239000013641 positive control Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000003556 assay Methods 0.000 description 4
- CJMJLDQKTOJACI-SEUSHGJOSA-N chembl2448612 Chemical group OC(=O)C(O)C(O)C(O)=O.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)=C1)C)C1=CC=CC=C1.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)=C1)C)C1=CC=CC=C1 CJMJLDQKTOJACI-SEUSHGJOSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229940095559 cafergot Drugs 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- XCGSFFUVFURLIX-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)=C1)C)C1=CC=CC=C1 XCGSFFUVFURLIX-VFGNJEKYSA-N 0.000 description 2
- 229960004943 ergotamine Drugs 0.000 description 2
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 102100024654 Calcitonin gene-related peptide type 1 receptor Human genes 0.000 description 1
- 108050009340 Endothelin Proteins 0.000 description 1
- 102000002045 Endothelin Human genes 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- 208000027109 Headache disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 1
- 101000760563 Homo sapiens Calcitonin gene-related peptide type 1 receptor Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229940124827 caffeine tablet Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
- CJMJLDQKTOJACI-BGQAIRJTSA-N ergotamine d-tartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)=C1)C)C1=CC=CC=C1.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)=C1)C)C1=CC=CC=C1 CJMJLDQKTOJACI-BGQAIRJTSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960001008 heparin sodium Drugs 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229960001660 histamine phosphate Drugs 0.000 description 1
- ZHIBQGJKHVBLJJ-UHFFFAOYSA-N histamine phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.NCCC1=CNC=N1 ZHIBQGJKHVBLJJ-UHFFFAOYSA-N 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229940079448 nitroglycerin 5 mg Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
组别 | n | 剂量(g/kg) | CGRP(pg/ml) | ET(pg/ml) | His(ng/ml) |
空白对照 | 8 | - | 134.09±4.96 | 228.21±16.44 | 64.53±4.12 |
模型对照 | 8 | 等容积蒸馏水 | 169.80±26.96** | 180.15±22.36** | 74.01±9.63* |
阳性对照 | 8 | 0.002 | 80.20±3.64△△ | 408.49±38.12△ | 54.14±1.78△△ |
高剂量 | 8 | 11.68 | 84.72±8.44△△ | 513.86±21.64○○△△ | 57.71±1.02△△ |
中剂量 | 8 | 5.84 | 63.60±5.44○○△△ | 338.59±10.74○○△△ | 49.34±3.45○△△ |
低剂量 | 8 | 2.92 | 42.19±9.88○○△△ | 218.57±25.13○○△△ | 42.72±2.86○○△△ |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005101059662A CN1943724B (zh) | 2005-10-08 | 2005-10-08 | 一种用于偏头痛的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005101059662A CN1943724B (zh) | 2005-10-08 | 2005-10-08 | 一种用于偏头痛的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1943724A true CN1943724A (zh) | 2007-04-11 |
CN1943724B CN1943724B (zh) | 2011-09-21 |
Family
ID=38043518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005101059662A Active CN1943724B (zh) | 2005-10-08 | 2005-10-08 | 一种用于偏头痛的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1943724B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103893570A (zh) * | 2012-12-29 | 2014-07-02 | 葵花药业集团(重庆)有限公司 | 一种用于治疗偏头痛的中药胶囊剂的制备方法 |
CN104906279A (zh) * | 2015-07-09 | 2015-09-16 | 青岛华仁技术孵化器有限公司 | 用于治疗偏头痛的中药组合物及其制备方法 |
US10799549B2 (en) * | 2015-09-11 | 2020-10-13 | Infinitus (China) Company Ltd. | Hepatoprotective traditional chinese medicine composition containing fructus ligustri lucidi, herba exliptae, radix paeoniae alba, rhizoma curcumae longae and clam extract, preparation method and use thereof |
-
2005
- 2005-10-08 CN CN2005101059662A patent/CN1943724B/zh active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103893570A (zh) * | 2012-12-29 | 2014-07-02 | 葵花药业集团(重庆)有限公司 | 一种用于治疗偏头痛的中药胶囊剂的制备方法 |
CN104906279A (zh) * | 2015-07-09 | 2015-09-16 | 青岛华仁技术孵化器有限公司 | 用于治疗偏头痛的中药组合物及其制备方法 |
US10799549B2 (en) * | 2015-09-11 | 2020-10-13 | Infinitus (China) Company Ltd. | Hepatoprotective traditional chinese medicine composition containing fructus ligustri lucidi, herba exliptae, radix paeoniae alba, rhizoma curcumae longae and clam extract, preparation method and use thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1943724B (zh) | 2011-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1943757B (zh) | 一种治疗偏头痛的中药组合物及其制备方法 | |
CN1824269A (zh) | 新生化口服液及其制备方法 | |
CN1943724B (zh) | 一种用于偏头痛的中药组合物及其制备方法 | |
CN101045152A (zh) | 一种治疗慢性盆腔炎伴炎性包块的中药组合物 | |
CN1242767C (zh) | 一种治疗肝纤维化疾病的中药复方制剂及其制备方法 | |
CN1679910A (zh) | 一种主治急慢性肝炎的药物 | |
CN1236810C (zh) | 一种治疗胃炎的中药 | |
CN1081042C (zh) | 中药戒毒药物组合物及其制备工艺 | |
CN1931286A (zh) | 一种用于治疗肺癌等引起的轻、中度癌性疼痛属气滞血瘀证的中药组合物 | |
CN1857492A (zh) | 清泻制剂及新的制备方法 | |
CN1895364A (zh) | 一种治疗脑血栓后遗症、风湿性关节炎的夏天无药物组合物 | |
CN1899574A (zh) | 一种防治肝癌的中药组合物及其应用 | |
CN1660352A (zh) | 一种具有协同作用的药物组合物 | |
CN1158093C (zh) | 含牦牛骨的治疗风湿病药物组合物及其制备方法 | |
CN1269518C (zh) | 一种治疗结核病的复方药物及其制备方法 | |
CN1333044A (zh) | 消渴降糖宝 | |
CN1657082A (zh) | 一种治疗病毒性心肌炎的口服中药组合物 | |
CN100339093C (zh) | 一种治疗冠心病、心绞痛的复方药物及其制备方法 | |
CN100342879C (zh) | 治疗肝纤维化的制剂及其制备方法 | |
CN103041189A (zh) | 一种治疗偏头痛的药物组合物及其制备方法 | |
CN1927366A (zh) | 一种用于慢性肠胃炎的中药组合物 | |
CN1911422A (zh) | 一种用于子宫内膜异位等症的中药组合物 | |
CN1579520A (zh) | 一种消栓通络的药物及其制备方法 | |
CN1660282A (zh) | 一种治疗乙型肝炎的药物组合物及其制备方法 | |
CN1063074C (zh) | 一种治疗肿瘤的中药注射液及制造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice |
Addressee: Jia Shiwei Document name: the First Notification of an Office Action |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SICHUAN ZI TONGGONG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHOU XIAOMING Effective date: 20121126 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Jian Inventor before: Zhou Xiaoming |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHOU XIAOMING TO: CHEN JIAN Free format text: CORRECT: ADDRESS; FROM: 100012 DONGCHENG, BEIJING TO: 641006 NEIJIANG, SICHUAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20121126 Address after: 641006 Neijiang City, Sichuan Province in central music town Vitex dam Patentee after: Sichuan Zitonggong Pharmaceutical Co., Ltd. Address before: 100012, No. 10, Qinglong dragon alley, Dongcheng District, Beijing Patentee before: Zhou Xiaoming |
|
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 641000 No. 456, Anji street, Neijiang economic and Technological Development Zone, Sichuan Patentee after: Sichuan zitonggong pharmaceutical Limited by Share Ltd Address before: 641006 Neijiang City, Sichuan Province in central music town Vitex dam Patentee before: Sichuan Zitonggong Pharmaceutical Co., Ltd. |